SG158921A1 - Compositions and methods for short interfering nucleic acid inhibition of nav1.8 - Google Patents
Compositions and methods for short interfering nucleic acid inhibition of nav1.8Info
- Publication number
- SG158921A1 SG158921A1 SG201000580-9A SG2010005809A SG158921A1 SG 158921 A1 SG158921 A1 SG 158921A1 SG 2010005809 A SG2010005809 A SG 2010005809A SG 158921 A1 SG158921 A1 SG 158921A1
- Authority
- SG
- Singapore
- Prior art keywords
- short interfering
- interfering nucleic
- compositions
- nucleic acid
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62248404P | 2004-10-27 | 2004-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG158921A1 true SG158921A1 (en) | 2010-02-26 |
Family
ID=36061603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201000580-9A SG158921A1 (en) | 2004-10-27 | 2005-10-26 | Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US7786291B2 (es) |
| EP (2) | EP1809745A2 (es) |
| JP (3) | JP2008517629A (es) |
| KR (1) | KR20070083828A (es) |
| CN (2) | CN102352355A (es) |
| AR (1) | AR051829A1 (es) |
| AU (1) | AU2005299310A1 (es) |
| CA (1) | CA2584785A1 (es) |
| IL (1) | IL182680A0 (es) |
| MX (1) | MX2007005069A (es) |
| NO (1) | NO20072692L (es) |
| SG (1) | SG158921A1 (es) |
| WO (1) | WO2006047687A2 (es) |
| ZA (1) | ZA200703453B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1942948A4 (en) * | 2005-11-04 | 2010-03-03 | Alnylam Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF THE NAV1.8 GENE |
| US8183221B2 (en) | 2007-09-05 | 2012-05-22 | Medtronic, Inc. | Suppression of SCN9A gene expression and/or function for the treatment of pain |
| ME02154B (me) | 2008-06-30 | 2015-10-20 | Janssen Pharmaceutica Nv | Proces za pripremu supstituisanih derivata pirimidina |
| MX337469B (es) | 2011-10-26 | 2016-03-02 | Pfizer Ltd | Derivados de (4-fenilimidazol-2-il)etilamina utiles como moduladores de canal de sodio. |
| TWI516593B (zh) * | 2012-06-11 | 2016-01-11 | 義守大學 | 一種聚核苷酸用以製備減緩疼痛藥物之用途 |
| AU2014255381A1 (en) | 2013-04-17 | 2015-10-08 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
| WO2016183123A1 (en) * | 2015-05-11 | 2016-11-17 | Alcyone Lifesciences, Inc. | Drug delivery systems and methods |
| BR112019012640A2 (pt) | 2016-12-21 | 2019-11-19 | Alcyone Lifesciences Inc | sistemas e métodos de entrega de fármaco |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513180D0 (en) * | 1995-06-28 | 1995-08-30 | Univ London | Ion channel |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| AU2001245793A1 (en) * | 2000-03-16 | 2001-09-24 | Cold Spring Harbor Laboratory | Methods and compositions for rna interference |
| KR101215789B1 (ko) * | 2000-03-30 | 2012-12-26 | 화이트헤드 인스티튜트 포 바이오메디칼 리서치 | Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체 |
| CZ302719B6 (cs) * | 2000-12-01 | 2011-09-21 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Izolovaná molekula dvouretezcové RNA, zpusob její výroby a její použití |
| GB0120238D0 (en) | 2001-08-20 | 2001-10-10 | Univ College Of London | Sodium channel regulators and modulators |
| US20060030534A1 (en) | 2002-09-04 | 2006-02-09 | Gabriele Dorn | Treatment of neurological disorders by dsrna administration |
| GB2400103A (en) | 2003-04-02 | 2004-10-06 | Ionix Pharmaceuticals Ltd | Cell lines expressing VGSC, Nav1.8 |
| ES2905724T3 (es) * | 2003-06-13 | 2022-04-11 | Alnylam Europe Ag | Acido ribonucleico bicatenario con elevada eficacia en un organismo |
| US7341835B2 (en) * | 2004-01-13 | 2008-03-11 | Affymetrix, Inc. | Methods of analysis of alternative splicing in mouse |
-
2005
- 2005-10-26 KR KR1020077009578A patent/KR20070083828A/ko not_active Application Discontinuation
- 2005-10-26 CN CN2011102887035A patent/CN102352355A/zh active Pending
- 2005-10-26 EP EP05825147A patent/EP1809745A2/en not_active Withdrawn
- 2005-10-26 CA CA002584785A patent/CA2584785A1/en not_active Abandoned
- 2005-10-26 US US11/259,588 patent/US7786291B2/en not_active Expired - Fee Related
- 2005-10-26 SG SG201000580-9A patent/SG158921A1/en unknown
- 2005-10-26 EP EP10011470A patent/EP2371954A1/en not_active Withdrawn
- 2005-10-26 AR ARP050104492A patent/AR051829A1/es not_active Application Discontinuation
- 2005-10-26 MX MX2007005069A patent/MX2007005069A/es active IP Right Grant
- 2005-10-26 WO PCT/US2005/038792 patent/WO2006047687A2/en active Application Filing
- 2005-10-26 CN CN2005800450905A patent/CN101103112B/zh not_active Expired - Fee Related
- 2005-10-26 JP JP2007539118A patent/JP2008517629A/ja not_active Withdrawn
- 2005-10-26 AU AU2005299310A patent/AU2005299310A1/en not_active Abandoned
-
2007
- 2007-04-19 IL IL182680A patent/IL182680A0/en unknown
- 2007-04-26 ZA ZA200703453A patent/ZA200703453B/en unknown
- 2007-05-25 NO NO20072692A patent/NO20072692L/no not_active Application Discontinuation
-
2010
- 2010-05-28 US US12/789,564 patent/US8309703B2/en not_active Expired - Fee Related
- 2010-09-06 JP JP2010199379A patent/JP2011015695A/ja not_active Withdrawn
-
2012
- 2012-10-16 US US13/653,013 patent/US8729045B2/en not_active Expired - Fee Related
-
2013
- 2013-05-10 JP JP2013100220A patent/JP2013176386A/ja active Pending
-
2014
- 2014-04-22 US US14/258,391 patent/US20140256787A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2584785A1 (en) | 2006-05-04 |
| JP2013176386A (ja) | 2013-09-09 |
| CN101103112A (zh) | 2008-01-09 |
| US7786291B2 (en) | 2010-08-31 |
| US8729045B2 (en) | 2014-05-20 |
| US8309703B2 (en) | 2012-11-13 |
| US20130109739A1 (en) | 2013-05-02 |
| CN101103112B (zh) | 2011-11-16 |
| JP2011015695A (ja) | 2011-01-27 |
| EP1809745A2 (en) | 2007-07-25 |
| EP2371954A1 (en) | 2011-10-05 |
| JP2008517629A (ja) | 2008-05-29 |
| CN102352355A (zh) | 2012-02-15 |
| US20060199779A1 (en) | 2006-09-07 |
| US20100305192A1 (en) | 2010-12-02 |
| AU2005299310A1 (en) | 2006-05-04 |
| WO2006047687A3 (en) | 2006-07-06 |
| US20140256787A1 (en) | 2014-09-11 |
| MX2007005069A (es) | 2007-06-25 |
| NO20072692L (no) | 2007-05-25 |
| ZA200703453B (en) | 2008-06-25 |
| KR20070083828A (ko) | 2007-08-24 |
| AR051829A1 (es) | 2007-02-14 |
| IL182680A0 (en) | 2007-09-20 |
| WO2006047687A2 (en) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG158921A1 (en) | Compositions and methods for short interfering nucleic acid inhibition of nav1.8 | |
| ATE534732T1 (de) | Molekulare targets und zusammensetzungen sowie verfahren zu deren identifikation zur behandlung von degenerations- und entzündungserkankungen | |
| WO2003080807A3 (en) | Compositions and methods for suppressing eukaryotic gene expression | |
| HK1050378A1 (en) | Inhibiting gene expression with dsrna | |
| WO2006031901A3 (en) | SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF | |
| WO2006135436A3 (en) | Inhibition of gene expression and therapeutic uses thereof | |
| MX2013010497A (es) | Inhibidores potentes y selectivos de nav1.3 y nav1.7. | |
| WO2004078940A8 (en) | USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 | |
| BR0108959A (pt) | Composições de poloxmero ou poloxamina melhoradas para distribuição de ácido nucléico | |
| TW200611910A (en) | Interferon-alpha polypeptides and conjugates | |
| IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
| Hall et al. | Repetitive DNA loci and their modulation by the non-canonical nucleic acid structures R-loops and G-quadruplexes | |
| DE602004022778D1 (de) | Mesenchymale stammzellen als vehikel für ionenkanaltransfer in synzytischen strukturen | |
| WO2007032794A3 (en) | Inhibition of viral gene expression using small interfering rna | |
| MX2007005474A (es) | Equipo de partes disenado para implementar un tratamiento antitumoral o antiviral en un mamifero. | |
| AU2004269200A8 (en) | Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins | |
| WO2004022782A3 (en) | Compositions and methods for tissue specific or inducible inhibition of gene expression | |
| TW200512293A (en) | Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics | |
| WO2001088124A3 (en) | Method and reagent for the inhibition of erg | |
| WO2009044158A3 (en) | Inhibitors and uses | |
| WO2011065677A3 (ko) | 암 치료용 약학 조성물 | |
| DE60333747D1 (de) | Dna-enzym zur hemmung von plasminogenaktivator-inhibitor-1 | |
| WO2009098690A3 (en) | Novel fer -like protein, pharmaceutical compositions containing it and method for its use | |
| EP1330156A4 (en) | MODULATION OF CYTOKINE OR HORMONE SIGNALING IN AN ANIMAL, INTEGRATING PROGRESSIVE REGULATION OF SOCS SEQUENCE EXPRESSION IN ANIMALS | |
| WO2005031788A3 (en) | A source of liquid metal ions and a method for controlling the source |